Cargando…
Toxicology issues related to the COVID–19 outbreak
In viral pandemics, such as coronavirus disease 2019 (COVID–19), the impact of real-life exposures to multiple toxic stressors that increase immune system dysfunction is followed by the main pandemic-associated virus (SARS–CoV–2, for COVID–19) exploiting the dysfunctional immune system to trigger a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342276/ http://dx.doi.org/10.1016/B978-0-323-85215-9.00017-9 |
_version_ | 1783734037607612416 |
---|---|
author | Kostoff, Ronald N. Briggs, Michael B. Porter, Alan L. |
author_facet | Kostoff, Ronald N. Briggs, Michael B. Porter, Alan L. |
author_sort | Kostoff, Ronald N. |
collection | PubMed |
description | In viral pandemics, such as coronavirus disease 2019 (COVID–19), the impact of real-life exposures to multiple toxic stressors that increase immune system dysfunction is followed by the main pandemic-associated virus (SARS–CoV–2, for COVID–19) exploiting the dysfunctional immune system to trigger a chain of events ultimately leading to the pandemic (COVID–19). Thus pandemics have two main components: virology (focused on the virus) and toxicology (focused on the toxic stressors). The present chapter will focus mainly on the immune system toxicology component. It identifies the factors shown most frequently to increase immune system dysfunction, and then addresses vaccine toxicology in detail. The chapter concludes by reviewing two types of treatments: immune-augmenting and immune-strengthening. The immune-augmenting approaches are virology-centric (e.g., quarantine, face masks, repurposed antiviral treatments, vaccines, etc.), and the immune-strengthening approaches are toxicology-centric (e.g., eliminating the factors that contribute to immune system dysfunction, and adding factors that increase immune system health). |
format | Online Article Text |
id | pubmed-8342276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-83422762021-08-06 Toxicology issues related to the COVID–19 outbreak Kostoff, Ronald N. Briggs, Michael B. Porter, Alan L. Toxicological Risk Assessment and Multi-System Health Impacts from Exposure Article In viral pandemics, such as coronavirus disease 2019 (COVID–19), the impact of real-life exposures to multiple toxic stressors that increase immune system dysfunction is followed by the main pandemic-associated virus (SARS–CoV–2, for COVID–19) exploiting the dysfunctional immune system to trigger a chain of events ultimately leading to the pandemic (COVID–19). Thus pandemics have two main components: virology (focused on the virus) and toxicology (focused on the toxic stressors). The present chapter will focus mainly on the immune system toxicology component. It identifies the factors shown most frequently to increase immune system dysfunction, and then addresses vaccine toxicology in detail. The chapter concludes by reviewing two types of treatments: immune-augmenting and immune-strengthening. The immune-augmenting approaches are virology-centric (e.g., quarantine, face masks, repurposed antiviral treatments, vaccines, etc.), and the immune-strengthening approaches are toxicology-centric (e.g., eliminating the factors that contribute to immune system dysfunction, and adding factors that increase immune system health). 2021 2021-08-06 /pmc/articles/PMC8342276/ http://dx.doi.org/10.1016/B978-0-323-85215-9.00017-9 Text en Copyright © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kostoff, Ronald N. Briggs, Michael B. Porter, Alan L. Toxicology issues related to the COVID–19 outbreak |
title | Toxicology issues related to the COVID–19 outbreak |
title_full | Toxicology issues related to the COVID–19 outbreak |
title_fullStr | Toxicology issues related to the COVID–19 outbreak |
title_full_unstemmed | Toxicology issues related to the COVID–19 outbreak |
title_short | Toxicology issues related to the COVID–19 outbreak |
title_sort | toxicology issues related to the covid–19 outbreak |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342276/ http://dx.doi.org/10.1016/B978-0-323-85215-9.00017-9 |
work_keys_str_mv | AT kostoffronaldn toxicologyissuesrelatedtothecovid19outbreak AT briggsmichaelb toxicologyissuesrelatedtothecovid19outbreak AT porteralanl toxicologyissuesrelatedtothecovid19outbreak |